| Mark Louis Jordan, MD | |
|
90 Bergen St, Doc 2300, Newark, NJ 07103-2425 | |
| (973) 972-2888 | |
| (973) 972-2892 |
| Full Name | Mark Louis Jordan |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 47 Years |
| Location | 90 Bergen St, Newark, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831121607 | NPI | - | NPPES |
| 6451608 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 25MA07557800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of California Irvine Medical Center | Orange, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Uci Department Of Urology | 6901799238 | 26 |
News Archive
A new study published on the preprint server medRxiv from King's College, London, suggests that an individual's genetic makeup may contribute to how much a person is likely to be affected by COVID-19, or whether they are likely to be infected at all.
When prostate cancer progresses to a more-dangerous metastatic state, it does so by resurrecting dormant molecular mechanisms that had guided the fetal development of the prostate gland but had been subsequently switched off, say scientists from Dana-Farber Cancer Institute.
A Simon Fraser University researcher has uncovered what may be the first quantified evidence demonstrating a relationship between upright locomotion and spinal health.
pHase Pharmaceuticals, LLC announces the launch of its new drug development company. pHase Pharmaceuticals is led by a cohesive team of drug development experts who have extensive experience bringing new drugs to market and garnering FDA approval.
› Verified 2 days ago
| Entity Name | Prohealth Partners, A Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003949975 PECOS PAC ID: 2769388412 Enrollment ID: O20031211000927 |
News Archive
A new study published on the preprint server medRxiv from King's College, London, suggests that an individual's genetic makeup may contribute to how much a person is likely to be affected by COVID-19, or whether they are likely to be infected at all.
When prostate cancer progresses to a more-dangerous metastatic state, it does so by resurrecting dormant molecular mechanisms that had guided the fetal development of the prostate gland but had been subsequently switched off, say scientists from Dana-Farber Cancer Institute.
A Simon Fraser University researcher has uncovered what may be the first quantified evidence demonstrating a relationship between upright locomotion and spinal health.
pHase Pharmaceuticals, LLC announces the launch of its new drug development company. pHase Pharmaceuticals is led by a cohesive team of drug development experts who have extensive experience bringing new drugs to market and garnering FDA approval.
› Verified 2 days ago
| Entity Name | Uci Department Of Urology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255398533 PECOS PAC ID: 6901799238 Enrollment ID: O20040202001148 |
News Archive
A new study published on the preprint server medRxiv from King's College, London, suggests that an individual's genetic makeup may contribute to how much a person is likely to be affected by COVID-19, or whether they are likely to be infected at all.
When prostate cancer progresses to a more-dangerous metastatic state, it does so by resurrecting dormant molecular mechanisms that had guided the fetal development of the prostate gland but had been subsequently switched off, say scientists from Dana-Farber Cancer Institute.
A Simon Fraser University researcher has uncovered what may be the first quantified evidence demonstrating a relationship between upright locomotion and spinal health.
pHase Pharmaceuticals, LLC announces the launch of its new drug development company. pHase Pharmaceuticals is led by a cohesive team of drug development experts who have extensive experience bringing new drugs to market and garnering FDA approval.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Louis Jordan, MD 30 Bergen St, Admc 12 1205, Newark, NJ 07107-3000 Ph: () - | Mark Louis Jordan, MD 90 Bergen St, Doc 2300, Newark, NJ 07103-2425 Ph: (973) 972-2888 |
News Archive
A new study published on the preprint server medRxiv from King's College, London, suggests that an individual's genetic makeup may contribute to how much a person is likely to be affected by COVID-19, or whether they are likely to be infected at all.
When prostate cancer progresses to a more-dangerous metastatic state, it does so by resurrecting dormant molecular mechanisms that had guided the fetal development of the prostate gland but had been subsequently switched off, say scientists from Dana-Farber Cancer Institute.
A Simon Fraser University researcher has uncovered what may be the first quantified evidence demonstrating a relationship between upright locomotion and spinal health.
pHase Pharmaceuticals, LLC announces the launch of its new drug development company. pHase Pharmaceuticals is led by a cohesive team of drug development experts who have extensive experience bringing new drugs to market and garnering FDA approval.
› Verified 2 days ago
Kunj Jain, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 185 S Orange Ave, Newark, NJ 07103 Phone: 732-445-4636 | |
Dr. Evan Kovac, MD CM FRCSC Urology Medicare: Accepting Medicare Assignments Practice Location: 140 Bergen St Rm G-1680, Newark, NJ 07103 Phone: 973-972-4418 | |
Dr. Gina Cambareri, MD Urology Medicare: Medicare Enrolled Practice Location: 201 Lyons Ave, L5, Newark, NJ 07112 Phone: 973-926-7280 | |
David S Ali, Urology Medicare: Medicare Enrolled Practice Location: 185 S Orange Ave, Newark, NJ 07103 Phone: 973-972-5682 |